MTNB
Price
$0.69
Change
+$0.02 (+2.99%)
Updated
Dec 24 closing price
Capitalization
4.43M
Intraday BUY SELL Signals
SPRC
Price
$1.40
Change
+$0.01 (+0.72%)
Updated
Dec 24 closing price
Capitalization
4.6M
Intraday BUY SELL Signals
Interact to see
Advertisement

MTNB vs SPRC

Header iconMTNB vs SPRC Comparison
Open Charts MTNB vs SPRCBanner chart's image
Matinas Biopharma Holdings
Price$0.69
Change+$0.02 (+2.99%)
Volume$3.85K
Capitalization4.43M
SciSparc
Price$1.40
Change+$0.01 (+0.72%)
Volume$54.9K
Capitalization4.6M
MTNB vs SPRC Comparison Chart in %
MTNB
Daily Signal:
Gain/Loss:
SPRC
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
MTNB vs. SPRC commentary
Dec 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MTNB is a Hold and SPRC is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 26, 2025
Stock price -- (MTNB: $0.69 vs. SPRC: $1.40)
Brand notoriety: MTNB and SPRC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MTNB: 14% vs. SPRC: 3%
Market capitalization -- MTNB: $4.43M vs. SPRC: $4.6M
MTNB [@Biotechnology] is valued at $4.43M. SPRC’s [@Biotechnology] market capitalization is $4.6M. The market cap for tickers in the [@Biotechnology] industry ranges from $117.47B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MTNB’s FA Score shows that 1 FA rating(s) are green whileSPRC’s FA Score has 1 green FA rating(s).

  • MTNB’s FA Score: 1 green, 4 red.
  • SPRC’s FA Score: 1 green, 4 red.
According to our system of comparison, MTNB is a better buy in the long-term than SPRC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MTNB’s TA Score shows that 5 TA indicator(s) are bullish while SPRC’s TA Score has 5 bullish TA indicator(s).

  • MTNB’s TA Score: 5 bullish, 4 bearish.
  • SPRC’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, SPRC is a better buy in the short-term than MTNB.

Price Growth

MTNB (@Biotechnology) experienced а -4.32% price change this week, while SPRC (@Biotechnology) price change was -10.26% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.88%. For the same industry, the average monthly price growth was +4.46%, and the average quarterly price growth was +55.39%.

Industries' Descriptions

@Biotechnology (+2.88% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SPRC($4.61M) and MTNB($4.43M) have the same market capitalization . MTNB YTD gains are higher at: 35.647 vs. SPRC (-81.481). SPRC has higher annual earnings (EBITDA): -6.97M vs. MTNB (-8.79M). MTNB has more cash in the bank: 5.44M vs. SPRC (1.54M). SPRC has less debt than MTNB: SPRC (46K) vs MTNB (2.33M). SPRC has higher revenues than MTNB: SPRC (1.31M) vs MTNB (0).
MTNBSPRCMTNB / SPRC
Capitalization4.43M4.61M96%
EBITDA-8.79M-6.97M126%
Gain YTD35.647-81.481-44%
P/E RatioN/A0.00-
Revenue01.31M-
Total Cash5.44M1.54M353%
Total Debt2.33M46K5,074%
FUNDAMENTALS RATINGS
MTNB: Fundamental Ratings
MTNB
OUTLOOK RATING
1..100
74
VALUATION
overvalued / fair valued / undervalued
1..100
19
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MTNBSPRC
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
89%
N/A
MACD
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 18 days ago
79%
Bullish Trend 17 days ago
84%
Declines
ODDS (%)
Bearish Trend 11 days ago
90%
Bearish Trend 7 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 2 days ago
81%
Aroon
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
MTNB
Daily Signal:
Gain/Loss:
SPRC
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PFX46.050.72
+1.59%
PhenixFIN Corp
IRWD3.260.05
+1.56%
Ironwood Pharmaceuticals
DNOW13.790.17
+1.25%
DNOW
OKTA88.39-0.67
-0.75%
Okta
GNPX1.86-0.03
-1.59%
Genprex Inc.

MTNB and

Correlation & Price change

A.I.dvisor indicates that over the last year, MTNB has been loosely correlated with PBYI. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if MTNB jumps, then PBYI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MTNB
1D Price
Change %
MTNB100%
+3.24%
PBYI - MTNB
38%
Loosely correlated
+0.85%
SPRC - MTNB
35%
Loosely correlated
+0.72%
AXON - MTNB
34%
Loosely correlated
+0.02%
VKTX - MTNB
32%
Poorly correlated
+2.58%
MDGL - MTNB
31%
Poorly correlated
+0.10%
More

SPRC and

Correlation & Price change

A.I.dvisor indicates that over the last year, SPRC has been loosely correlated with ASMB. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if SPRC jumps, then ASMB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SPRC
1D Price
Change %
SPRC100%
+0.72%
ASMB - SPRC
45%
Loosely correlated
+3.88%
GYRE - SPRC
38%
Loosely correlated
+0.14%
MTNB - SPRC
36%
Loosely correlated
+3.24%
ALZN - SPRC
31%
Poorly correlated
-1.12%
NKTX - SPRC
30%
Poorly correlated
+0.56%
More